“As a practical matter, there’s not much time for [the government] to pull this off, especially given other priorities related to the pandemic,” said Tricia Neuman, executive director of the Kaiser Family Foundation’s Medicare policy program.
The Biden administration, which takes over Jan. 20, is not expected to support the cards, which have received criticism for their cost ($7.9 billion) and questionable legality.
Trump first pushed his plan during a campaign speech delivered in Charlotte, North Carolina, in late September. The White House has said the cards would be paid for under a Medicare program that’s generally intended to test innovations to lower prices or improve health care.
Source Article from https://www.cnbc.com/2020/12/15/trumps-plan-for-200-medicare-drug-cards-progresses-hurdles-remain.html
Comments